Daesang Corporation revealed it backed out from its plan to buy the China-based food company, Heilongjiang Chengfu Food Group Co. It aimed to acquire a 51% stake in the company, which has now been withdrawn.
According to The Korea Economic Daily, the original plan was to purchase over half of the company's stake, trimmed to 20%. The South Korean food giant reportedly changed its decision as the amino acid product market slowed.
Purpose of the Initial Bid
Daesang Corp. was trying to acquire a controlling stake in Heilongjiang Chengfu Food to increase its presence in the Chinese market. The latter is a leading food additives manufacturer in China, and its position would also benefit Daesang.
Daesang and Heilongjiang Chengfu Food already agreed to an up to 51% acquisition deal in 2021, worth KRW26.5 billion. However, the former announced on Thursday this week that it will just buy 20% of Chengfu Food for KRW8.84 billion. The company said the acquisition may be completed by Sept. 7
"We had to make changes to our deal given the sluggishness of the lysine business in China. Through our minority stake investment, however, we will continue cooperating with Chengfu Food in functional amino acid products such as L-arginine for feed and L-tryptophan," a Daesang official said.
Sluggish Market Pushed Daesang to Retract Bid
Finally, Daesang Group stressed that the slow market for lysine has prompted it to retract its bid. As per the Financial Supervisory Service's Electronic Disclosure System, the company revised its plan for the deal and has now reduced the stake it would buy. New Daily reported that the expected share will also be reduced from 32.87% to 20%.
Photo by: Daesang Website


Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 



